These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 17557086)
1. User-fee bill passes US Senate, but legislative hurdles remain. Fox JL Nat Biotechnol; 2007 Jun; 25(6):611. PubMed ID: 17557086 [No Abstract] [Full Text] [Related]
2. Pharmaceutical costs. An overview and analysis of legal and policy responses by the states. Latham SR J Leg Med; 2003 Jun; 24(2):141-73. PubMed ID: 12775406 [No Abstract] [Full Text] [Related]
3. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration? Zelenay JL Food Drug Law J; 2005; 60(2):261-338. PubMed ID: 16094773 [No Abstract] [Full Text] [Related]
4. PDUFA reauthorization--drug safety's golden moment of opportunity? Hennessy S; Strom BL N Engl J Med; 2007 Apr; 356(17):1703-4. PubMed ID: 17435082 [No Abstract] [Full Text] [Related]
5. Paying for drug approvals--who's using whom? Avorn J N Engl J Med; 2007 Apr; 356(17):1697-700. PubMed ID: 17435083 [No Abstract] [Full Text] [Related]
6. Gift giving. Raszkowski RR S D J Med; 2002 Dec; 55(12):513-4. PubMed ID: 12516357 [No Abstract] [Full Text] [Related]
7. Medicaid drug bill mandates pharmaceutical discounts. Blankenship N Provider; 1991 Jan; 17(1):45. PubMed ID: 10108564 [No Abstract] [Full Text] [Related]
8. US Senate passes FDA Revitalization Act. Guthrie P CMAJ; 2007 Jul; 177(1):23. PubMed ID: 17606930 [No Abstract] [Full Text] [Related]
9. FDA user fees approved. Clin Pharm; 1993 Jan; 12(1):3. PubMed ID: 8428431 [No Abstract] [Full Text] [Related]
10. No room for compromise. Bill C-22. McGillivray D CPJ; 1988 Feb; 121(2):88-9. PubMed ID: 10285967 [No Abstract] [Full Text] [Related]
11. FDA user fee law poised for passage in Congress but not without stirring up controversy. Finkelstein J J Natl Cancer Inst; 2007 Jul; 99(14):1072-3. PubMed ID: 17623792 [No Abstract] [Full Text] [Related]
12. The Prescription Drug User Fee Act of 1992. A 5-year experiment for industry and the FDA. Shulman SR; Kaitin KI Pharmacoeconomics; 1996 Feb; 9(2):121-33. PubMed ID: 10160091 [TBL] [Abstract][Full Text] [Related]
13. Medicare should bargain for lower drug prices, study says. Med Health; 2005 Oct; 59(36):1, 3, 7. PubMed ID: 16240494 [No Abstract] [Full Text] [Related]
14. The marketplace can't give us the drug safety data we need. Avorn J MedGenMed; 2007 Feb; 9(1):29. PubMed ID: 17435636 [No Abstract] [Full Text] [Related]
15. Tempered enthusiasm. Drug-safety law needs more teeth, patient-safety advocates say. DerGurahian J Mod Healthc; 2007 Oct; 37(40):16. PubMed ID: 18018373 [No Abstract] [Full Text] [Related]
16. Legal Challenges to State Drug Pricing Laws. Lee TT; Kesselheim AS; Kapczynski A JAMA; 2018 Mar; 319(9):865-866. PubMed ID: 29435585 [No Abstract] [Full Text] [Related]
18. Price controls and global pharmaceutical progress. Scherer FM Health Aff (Millwood); 2009; 28(1):w161-4. PubMed ID: 19088103 [TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical company user fees: their uses and abuses. Miller HI Am J Ther; 2009; 16(6):475-6. PubMed ID: 19797940 [No Abstract] [Full Text] [Related]
20. Possible anticompetitive agreements between brand, generic companies to be studied. Landis NT Am J Health Syst Pharm; 2000 Dec; 57(23):2140, 2142. PubMed ID: 11127691 [No Abstract] [Full Text] [Related] [Next] [New Search]